Free Trial

eFFECTOR Therapeutics (EFTR) Earnings Date, Estimates & Call Transcripts

$1.78
-0.04 (-2.20%)
(As of 05/24/2024 08:49 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(Mar. 25)
-$3.42 Missed By -$0.69
Consensus EPS
(Mar. 25)
-$2.73
Skip Charts & View Estimated and Actual Earnings Data

EFTR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EFTR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

eFFECTOR Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($2.06)($2.06)($2.06)
Q2 20241($1.53)($1.53)($1.53)
Q3 20241($1.22)($1.22)($1.22)
Q4 20241($1.02)($1.02)($1.02)
FY 20244($5.83)($5.83)($5.83)

EFTR Earnings Date and Information

eFFECTOR Therapeutics last issued its quarterly earnings data on March 25th, 2024. The reported ($3.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.73) by $0.69. eFFECTOR Therapeutics has generated ($13.08) earnings per share over the last year (($13.08) diluted earnings per share). Earnings for eFFECTOR Therapeutics are expected to grow in the coming year, from ($5.63) to ($2.25) per share. eFFECTOR Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

eFFECTOR Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
3/25/2024Q4 2023($2.73)($3.42)($0.69)($3.42)--
11/13/2023Q3 2023($3.25)($3.25)-($0.13)--
8/8/2023Q2 2023($4.75)($4.25)+$0.50($0.17)--
5/9/2023Q1 2023($5.50)($6.00)($0.50)($0.24)--
3/8/2023Q4 2022($4.50)($5.50)($1.00)($0.22)-$0.67 million
11/7/2022Q3 2022($6.75)($5.75)+$1.00($0.23)-$0.87 million
8/9/2022Q2 2022($4.50)($4.25)+$0.25($0.17)-$2.01 million
5/10/2022Q1 2022($8.00)$1.75+$9.75$0.07--
3/16/2022Q4 2021($6.25)$11.00+$17.25$0.44-$0.31 million
11/8/2021Q3 2021($6.50)$10.50+$17.00$0.42-$0.43 million

eFFECTOR Therapeutics Earnings - Frequently Asked Questions

When is eFFECTOR Therapeutics's earnings date?

eFFECTOR Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on EFTR's earnings history.

Did eFFECTOR Therapeutics beat their earnings estimates last quarter?

In the previous quarter, eFFECTOR Therapeutics (NASDAQ:EFTR) missed the analysts' consensus estimate of ($2.73) by $0.69 with a reported earnings per share (EPS) of ($3.42). Learn more on analysts' earnings estimate vs. EFTR's actual earnings.

How much revenue does eFFECTOR Therapeutics generate each year?

eFFECTOR Therapeutics (NASDAQ:EFTR) has a recorded annual revenue of $3.55 million.

How much profit does eFFECTOR Therapeutics generate each year?

eFFECTOR Therapeutics (NASDAQ:EFTR) has a recorded net income of -$35.81 million. EFTR has generated -$13.08 earnings per share over the last four quarters.

What is eFFECTOR Therapeutics's EPS forecast for next year?

eFFECTOR Therapeutics's earnings are expected to grow from ($5.63) per share to ($2.25) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:EFTR) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners